S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
OTCMKTS:NRXGQ

NephroGenex (NRXGQ) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2,000 shs
Average Volume
26,223 shs
Market Capitalization
$36,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NRXGQ stock logo

About NephroGenex Stock (OTCMKTS:NRXGQ)

NephroGenex, Inc. is a pharmaceutical company. The Company is focused on the development of therapeutics to treat kidney disease. The Company has paused the clinical program of its product candidate, oral Pyridorin, for the treatment of diabetic nephropathy. The Company was primarily focused on the Phase III Pyridorin program, and other planned clinical and nonclinical studies and other work needed to submit Pyridorin for acute kidney injury (AKI), as well as the treatment of diabetic nephropathy in patients with Type II diabetes for regulatory approval in the United States and Europe. The Company has not generated any revenues.

NRXGQ Stock News Headlines

Elicera Therapeutics AB (ELIC)
LL Lucky Games publ AB (LADYLU)
Biden out June 13; Kamala won’t replace him?
On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.
Xinjiang Daqo New Energy Co Ltd (688303)
Tsukuba Bank Ltd (8338)
PEXA Group Ltd (PXA)
Kosei Securities Co Ltd (8617)
Nusatama Berkah Tbk PT (NTBK)
Biden out June 13; Kamala won’t replace him?
On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.
Olympic Group Corp (8289)
Okinawa financial Group Inc (7350)
Selvas Healthcare Inc (208370)
Al-Bad Massuot Yitzhak Ltd (ALBA)
Seven Utilities and Power PCL (7UP)
Yong Pyong Resort Corp (070960)
Aksa Enerji Uretim AS (AKSEN)
MHP Hotel AG (CDZ0)
See More Headlines
Receive NRXGQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NephroGenex and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Electronic Computer Manufacturing
Sub-Industry
N/A
Current Symbol
OTCMKTS:NRXGQ
Previous Symbol
NASDAQ:NRX
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$36,000.00
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • John P. Hamill CPA
    Chief Executive Officer, Chief Financial Officer

NRXGQ Stock Analysis - Frequently Asked Questions

How do I buy shares of NephroGenex?

Shares of NRXGQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NRXGQ) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners